A I-designed compounds can kill drug-resistant bacteria

Share via:


The top candidates they discovered are structurally distinct from any existing antibiotics, and they appear to work by novel mechanisms that disrupt bacterial cell membranes. This makes them less vulnerable to antibiotic resistance, a growing problem: It is estimated that drug-­resistant bacterial infections cause nearly 5 million deaths per year worldwide.

Now that they can generate and evaluate compounds that have never been seen before, the researchers hope they can use the same strategy to…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

A I-designed compounds can kill drug-resistant bacteria


The top candidates they discovered are structurally distinct from any existing antibiotics, and they appear to work by novel mechanisms that disrupt bacterial cell membranes. This makes them less vulnerable to antibiotic resistance, a growing problem: It is estimated that drug-­resistant bacterial infections cause nearly 5 million deaths per year worldwide.

Now that they can generate and evaluate compounds that have never been seen before, the researchers hope they can use the same strategy to…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

trump: From AI to chips, Big Tech is getting...

Before President Donald Trump returned to the White...

Martin Fowler on Preparing for AI’s Nondeterministic Computing

Martin Fowler, Thoughtworks chief scientist and long-time expert...

The 33 top health and wellness startups from Disrupt...

Every year, TechCrunch’s Startup Battlefield pitch contest draws...

Popular